Protein Dx Firm Courtagen Raises $8M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Courtagen Life Sciences has raised $8 million in equity funding, the company disclosed in a regulatory filing on Friday.

The document filed with the US Securities Exchange Commission did not reveal how the funds will be used or who the participants in the round were but said that there were 67 investors.

A company spokesperson did not respond to a request for comment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.